Meenaakshi Molecules Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 28-06-2024
- Paid Up Capital ₹ 0.50 M
as on 28-06-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 62.52%
(FY 2023)
- Profit 827.10%
(FY 2023)
- Ebitda 202.33%
(FY 2023)
- Net Worth 21.93%
(FY 2023)
- Total Assets 319.22%
(FY 2023)
About Meenaakshi Molecules
The Corporate was formerly known as Meenakshi Mongers Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Madhavi Venkamasetty and Anjaiah Venkamasetty serve as directors at the Company.
- CIN/LLPIN
U52100TG2014PTC092073
- Company No.
092073
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2014
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Secunderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Meenaakshi Molecules?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjaiah Venkamasetty  | Managing Director | 02-Jan-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhavi Venkamasetty | Whole-Time Director | 02-Jan-2014 | Current |
Financial Performance and Corporate Structure Insights of Meenaakshi Molecules.
Meenaakshi Molecules Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.52% increase. The company also saw a substantial improvement in profitability, with a 827.1% increase in profit. The company's net worth Soared by an impressive increase of 21.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meenaakshi Molecules?
In 2023, Meenaakshi Molecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meenaakshi Molecules?
Unlock and access historical data on people associated with Meenaakshi Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meenaakshi Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meenaakshi Molecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
